Xencor's average Accounts Receivable for the
three
months ended in Dec. 2023 was $33.1 Mil. Xencor's Revenue for the
three
months ended in Dec. 2023 was $44.7 Mil.
Hence, Xencor's Days Sales Outstanding for the
three
months ended in Dec. 2023 was 67.68.
The historical rank and industry rank for Xencor's Days Sales Outstanding or its related term are showing as below:
XNCR'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 14.5 Med: 46.4 Max: 105.77
Current: 58.62
During the past 13 years, Xencor's highest Days Sales Outstanding was 105.77. The lowest was 14.50. And the median was 46.40.
XNCR's Days Sales Outstanding is ranked better than 60.85% of 889
companies
in the Biotechnology industry
Industry Median: 71.97
vs XNCR: 58.62
Xencor's Days Sales Outstanding
declined
from Dec. 2022 (155.97) to Dec. 2023 (67.68).
Xencor Days Sales Outstanding Historical Data
The historical data trend for Xencor's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Xencor's Days Sales Outstanding
For the Biotechnology subindustry, Xencor's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Xencor's Days Sales Outstanding Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Xencor's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Xencor's Days Sales Outstanding falls into.
Xencor Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Xencor (NAS:XNCR) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Xencor Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Xencor's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045 and XmAb13676. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XNCR has been successfully added to your 